fullerene c60 has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, T; Masuko, K; Matsubayashi, K; Murayama, H; Nakamura, H; Nishioka, K; Shishido, K; Takada, H; Yano, M; Yudoh, K | 1 |
| Bar-Shir, A; Basso, AS; Costa-Pinto, FA; Engel, Y; Frenkel, D; Gozin, M; Monsonego, A; Petrovic-Stojkovic, S; Puckett, L; Quintana, FJ; Weiner, HL | 1 |
2 other study(ies) available for fullerene c60 and Disease Exacerbation
| Article | Year |
|---|---|
Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Animals; Apoptosis; Cartilage, Articular; Cells, Cultured; Cellular Senescence; Chondrocytes; Disease Models, Animal; Disease Progression; Down-Regulation; Free Radical Scavengers; Fullerenes; Humans; Hyaluronic Acid; In Vitro Techniques; Osteoarthritis, Knee; Oxidative Stress; Rabbits | 2007 |
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
Topics: Amino Acid Transport System X-AG; Animals; Astrocytes; Axons; B-Lymphocytes; CD11b Antigen; Chemokine CCL2; Chronic Disease; Disease Models, Animal; Disease Progression; Fullerenes; Glutamic Acid; Memory; Mice; Molecular Structure; Multiple Sclerosis; Oxidative Stress; T-Lymphocytes | 2008 |